血液DNA甲基化模型改善2型糖尿病短期心血管风险分层
研究在305例2型糖尿病患者的基线外周血单核细胞中分析全表观基因组DNA甲基化,其中81例5年内发生主要不良心血管事件(MACE),224例未发生。研究随机划分训练集与内部测试集,采用LASSO逻辑回归结合稳定性选择构建5个DNAm模型,测试集AUC为0.915–0.937,提示DNAm模型可能改善短期心血管事件风险分层。
要点
- 基于血液DNAm的模型在2型糖尿病人群中区分5年内MACE的AUC达0.915–0.937。
- 五个分析框架分别识别出23,839至7,101个差异甲基化CpG位点,各模型保留22–26个CpG预测因子。
- 12个CpG位点在所有模型中均被识别,与MACE风险升高或降低独立相关。
核心结论
- 基于DNAm的模型可能改善2型糖尿病患者的短期心血管事件风险分层,有助于识别MACE高风险个体。
研究设计与样本
- 研究纳入TOSCA.IT试验中305例2型糖尿病参与者,基线采集外周血单核细胞进行全表观基因组DNAm分析。
- 人群随机分为训练集和内部测试集,用于模型开发与评估;81例在5年内发生MACE,224例未发生。
主要发现
- 五个分析框架分别识别出23,839、21,529、21,500、12,114和7,101个差异甲基化CpG位点。
- LASSO逻辑回归构建五个DNAm模型,稳定性选择每个模型保留22–26个CpG预测因子。
- 内部测试集中五个模型ROC AUC为0.915–0.937,PR AUC为0.866–0.940。
- 多个CpG与MACE风险升高或降低独立相关,其中12个CpG在所有模型中均被识别。
临床怎么用
- 对于2型糖尿病患者,可考虑基于血液DNAm模型辅助短期MACE风险分层,以细化高风险人群识别。
局限性
- 研究基于TOSCA.IT试验人群,样本量305例,结果需外部验证。
- 模型评估采用内部测试集随机划分,尚未在独立队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular complications are the leading cause of death in type 2 diabetes mellitus (T2DM). We investigated whether blood-based DNA methylation (DNAm) biomarkers could improve risk stratification for major adverse cardiovascular events (MACE) in individuals with T2DM. RESEARCH DESIGN AND METHODS: Epigenome-wide DNAm was profiled in peripheral blood mononuclear cells obtained at baseline from 305 T2DM participants of the Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents. Intervention Trial (TOSCA.IT) study, including 81 who experienced MACE within 5 years (T2DMACE) and 224 who did not (T2D). The population was randomly divided into training and internal test sets for model development and evaluation. Differential DNAm analyses were performed under five frameworks differing by covariate adjustment. Binomial least absolute shrinkage and selection operator (LASSO) logistic regression with stability selection was used to generate DNAm-based models to stratify individuals at higher risk of incident MACE over 5 years. RESULTS: Differential DNAm analysis identified 23,839, 21,529, 21,500, 12,114, and 7,101 differentially methylated CpG sites across the five analytical frameworks. LASSO logistic regression was used to develop five DNAm-based models. Stability selection retained 22-26 CpG predictors per model. When evaluated in the internal test cohort, the five models showed high discriminative performance, with receiver operating characteristic area under the curve values ranging from 0.915 to 0.937 and area under the precision-recall curve values from 0.866 to 0.940. Several CpGs were independently associated with either increased or decreased risk of MACE, including 12 CpGs identified across all of the models. CONCLUSIONS: The DNAm-based models we have generated may improve risk stratification for short-term cardiovascular events in individuals with T2DM, providing a promising approach to refine identification of those at increased risk of MACE.
引用
- Longo M, Desiderio A, Masulli M, et al. Blood-Based DNA Methylation Models Improve Short-term Cardiovascular Risk Stratification in Individuals With Type 2 Diabetes. Diabetes Care. 2026. PMID: 42461785. doi:10.2337/dc26-0738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。